Another drawback of the kit seemed to be the measurement of total MMP-9 levels. In certain samples, the levels of total MMP-9 were surprisingly lower as compared with those of active MMP-9. The explanation for these findings by Amersham Pharmacia Biotech, was that the already active MMP-9 (68kDa) can be "over-activated" by APMA and hence processed into too small molecular weight form that is either not immobilized by the antibody, or is no longer truly active. If the majority of the MMP-9 content of this sample is naturally endogenous active MMP-9, this will result in high endogenous active MMP-9 readings but low total MMP-9, once the active MMP-9 has been over-activated.
After this experience we decided to focus only on total MMP-9 and TIMP-1 for the protein levels since our samples from the clinical study were already frozen and for cell experiments also on mRNA levels (1).
For the measurement of total MMP-9 levels in human urine, a commercial ELISA kit (R&D systems, Abingdon, UK), which recognizes total human MMP-9, was used. We employed the kit from Amersham only for the measurement of total mouse MMP-9 levels since there was no such kit available from another company at the time of analyzing the results.
